India's drug regulatory agency has approved new eye drops that can help remove reading glasses in people who have presbyopia. These new eye drops, known as PresVuand manufactured by Mumbai-based ...
Patients saw an average improvement of around three lines on a near vision standard eye chart compared to placebo, without compromising the clarity of their distance vision. Presbyopia is caused ...
Press Release Tenpoint Therapeutics, Limited ("Tenpoint") and Visus Therapeutics, Inc., ("Visus") announce today the completion of their merger to create an entirely new chapter in ophthalmic ...
The global market for myopia and presbyopia treatment has witnessed significant momentum, driven by increasing cases of vision impairment and the growing prevalence of age-related eye conditions. With ...
Eye-focused biotechs Tenpoint Therapeutics and Visus Therapeutics are joining forces, setting their sights on filing a new drug approval application next year for a presbyopia-correcting eye drop.
Lento Bio Inc. has synthesized cysteine derivatives reported to be useful for the treatment of presbyopia. An exemplified compound (Cpd in row 4 in tbl1 pg 20, claim 18) decreased in lens stiffness in ...
Presbyopia is caused by a stiffening in the lens of the eye that develops in people after the age of 40, and affects an estimated 128 million people in the US, and seems to be becoming more of a ...